Alzheimer’s Treatment Controversy, Science Mistakes, Chonky Fish. June 11, 2020, Part 2

On this episode

About this episode

FDA’s Approval Of Debated Alzheimer’s Treatment Raises Controversy This week, the FDA gave the green light to a drug for the treatment of Alzheimer’s disease. The drug, a monoclonal antibody called aducanumab, is the first Alzheimer’s treatment to receive approval in almost 20 years. It targets the amyloid protein that forms the tangled plaques found in the brains of people with Alzheimer’s. But while researchers agree that aducanumab leads to less amyloid plaque, no one really knows what that means in terms of real benefits for people with the disease. Researchers still don’t understand the role of amyloid in the progression of Alzheimer’s disease—and in two studies conducted by the…